Condition
HIE - Hypoxic - Ischemic Encephalopathy
Total Trials
4
Recruiting
2
Active
2
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 4 trials
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
1Total
P 4 (1)
Trial Status
Recruiting2
Not Yet Recruiting1
Unknown1
Clinical Trials (4)
Showing 4 of 4 trials
NCT07413900RecruitingPrimary
Biomarkers Study in Infants With Prior Neonatal Brain Injury
NCT07284498Phase 4Not Yet Recruiting
Treatment of Seizures in Neonate With HIE
NCT07136636RecruitingPrimary
Speech of Kids After Neonatal Encephalopathy
NCT04728438Unknown
Effect of Targeted Temperature Management on Cerebral Autoregulation in Patients With Neurocritical Diseases
Showing all 4 trials